272 related articles for article (PubMed ID: 23079809)
1. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA
AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809
[TBL] [Abstract][Full Text] [Related]
2. Cancer treatment disparities in HIV-infected individuals in the United States.
Suneja G; Shiels MS; Angulo R; Copeland GE; Gonsalves L; Hakenewerth AM; Macomber KE; Melville SK; Engels EA
J Clin Oncol; 2014 Aug; 32(22):2344-50. PubMed ID: 24982448
[TBL] [Abstract][Full Text] [Related]
3. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
[TBL] [Abstract][Full Text] [Related]
4. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
5. Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?
Lee JY; Moore PC; Steliga MA
Med Care; 2013 Dec; 51(12):1063-8. PubMed ID: 24220684
[TBL] [Abstract][Full Text] [Related]
6. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care of nonsmall cell lung cancer patients in China and implications for survival.
He Y; Yu XQ; Luo Q; Xu X; Wang Y; Li S; Shan B
J Cancer Res Ther; 2018 Jun; 14(Supplement):S410-S415. PubMed ID: 29970698
[TBL] [Abstract][Full Text] [Related]
8. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
9. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in HIV-infected patients with non-small cell lung cancer.
Sigel K; Crothers K; Dubrow R; Krauskopf K; Jao J; Sigel C; Moskowitz A; Wisnivesky J
Br J Cancer; 2013 Oct; 109(7):1974-80. PubMed ID: 24022194
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
[TBL] [Abstract][Full Text] [Related]
14. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.
Marcus JL; Chao C; Leyden WA; Xu L; Yu J; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1167-73. PubMed ID: 25713023
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer incidence and survival among HIV-infected and uninfected women and men.
Hessol NA; Martínez-Maza O; Levine AM; Morris A; Margolick JB; Cohen MH; Jacobson LP; Seaberg EC
AIDS; 2015 Jun; 29(10):1183-93. PubMed ID: 25888645
[TBL] [Abstract][Full Text] [Related]
16. Disparities in cancer treatment among patients infected with the human immunodeficiency virus.
Suneja G; Lin CC; Simard EP; Han X; Engels EA; Jemal A
Cancer; 2016 Aug; 122(15):2399-407. PubMed ID: 27187086
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
18. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
20. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care.
Brock MV; Hooker CM; Engels EA; Moore RD; Gillison ML; Alberg AJ; Keruly JC; Yang SC; Heitmiller RF; Baylin SB; Herman JG; Brahmer JR
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):47-55. PubMed ID: 16936558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
